Coastal Bridge Advisors, LLC Processa Pharmaceuticals, Inc. Transaction History

Coastal Bridge Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$0.18 - $0.84 $2,242 - $10,463	12,456 Added 23.73%	64,956 $22,000
Q2 2022 Aug 05, 2022	BUY	$1.68 - $3.55 $33,600 - $71,000	20,000 Added 61.54%	52,500 $148,000
Q4 2021 Feb 14, 2022	BUY	$4.03 - $8.42 $20,150 - $42,100	5,000 Added 18.18%	32,500 $159,000
Q2 2021 Aug 10, 2021	BUY	$6.15 - $10.95 $46,125 - $82,125	7,500 Added 37.5%	27,500 $225,000
Q1 2021 May 17, 2021	BUY	$5.96 - $13.15 $119,200 - $263,000	20,000 New	20,000 $218,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $14.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.